← FDA Drug Approvals (Drugs@FDA)
ICATIBANT ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: JIANGSU HANSOH PHARM · Approved 2020-03-09
Drug application
- FDA Application #
ANDA211021- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ICATIBANT ACETATE
- Generic name
- ICATIBANT
- Active ingredients
- ICATIBANT ACETATE
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- JIANGSU HANSOH PHARM
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- First approval
- 2020-03-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown